Skip to main content

Walker Matthew Allen's Form 4 filing

GreenLight Biosciences Holdings, PBCGRNA · filed Feb 4, 2022

Accession no.
0001062993-22-002745
Filed
Feb 4, 2022, 8:22 PM ET
Trade date
Feb 2, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 2 non-derivative transactions. Open-market purchases total $15.0M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Walker Matthew AllenCIK 0001908721Director, 10% Owner
Builders Vision, LLCCIK 000178550410% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Feb 2, 2022Common StockAGrant or awardAcquired+14,343,021–F1–14,343,021Indirect
Feb 2, 2022Common StockPPurchaseAcquired+1,500,000$10.00F4+$15,000,00015,843,021Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F1

Issued pursuant to the terms of a business combination agreement involving the issuer and GreenLight Biosciences, Inc. in exchange for capital stock previously issued by such company.

Referenced by the price of 1 transaction in Table I.

F4

Amount consists of 1,500,000 shares of common stock issued pursuant to a subscription agreement entered into between the Issuer and S2G Builders Food & Agriculture Fund III, L.P.

Referenced by the price of 1 transaction in Table I.

Remarks

S2G Advisors, LLC has changed its name to Builders Vision, LLC. Mr. Walker's middle name is spelled Allen, not Alan.

Read the full filing on SEC EDGAR (opens in a new tab)